Patients with schizophrenia, whose current medication is not fully effective, will participate in a clinical trial to see if CBD is safe and effective when used alongside an anti-psychotic drug, according to a newly registered clinical trial.
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases.
CBD has beneficial effects in patients with schizophrenia and may represent a new class of treatment for the disorder.